107 related articles for article (PubMed ID: 11491226)
41. Oral hairy leukoplakia in an HIV-negative patient.
Graboyes EM; Allen CT; Chernock RD; Diaz JA
Ear Nose Throat J; 2013 Jun; 92(6):E12. PubMed ID: 23780596
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus and Epstein Barr virus in oral hairy leukoplakia among HIV positive Venezuelan patients.
Correnti M; González X; Avila M; Perrone M; Rivera H
Acta Odontol Latinoam; 2010; 23(2):117-23. PubMed ID: 21053684
[TBL] [Abstract][Full Text] [Related]
43. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India.
Ranganathan K; Geethalakshmi E; Krishna Mohan Rao U; Vidya KM; Kumarasamy N; Solomon S
Int J Paediatr Dent; 2010 Jul; 20(4):276-82. PubMed ID: 20536589
[TBL] [Abstract][Full Text] [Related]
44. Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1.
Vaseliu N; Carter AB; Kline NE; Kozinetz C; Cron SG; Matusa R; Kline MW
Pediatr Infect Dis J; 2005 Dec; 24(12):1067-71. PubMed ID: 16371867
[TBL] [Abstract][Full Text] [Related]
45. Predicting outcomes in HIV-infected veterans: I. Progression to AIDS.
Rabeneck L; Hartigan PM; Huang IW; Souchek J; Wray NP
J Clin Epidemiol; 1997 Nov; 50(11):1231-40. PubMed ID: 9393379
[TBL] [Abstract][Full Text] [Related]
46. Pseudo oral hairy leukoplakia in a renal allograft recipient.
Euvrard S; Kanitakis J; Pouteil-Noble C; Chardonnet Y; Touraine JL; Thivolet J
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 2):300-3. PubMed ID: 8294586
[TBL] [Abstract][Full Text] [Related]
47. [Oral hairy leukoplakia: histopathologic features of subclinical stage].
Dias EP; Spyrides KS; Silva Júnior AS; Rocha ML; da Fonseca EC
Pesqui Odontol Bras; 2001; 15(2):104-11. PubMed ID: 11705191
[TBL] [Abstract][Full Text] [Related]
48. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
[TBL] [Abstract][Full Text] [Related]
49. Infection fighters. High-dose Valtrex for oral hairy leukoplakia.
TreatmentUpdate; 2003; 15(7):6-7. PubMed ID: 17216869
[No Abstract] [Full Text] [Related]
50. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia.
Moura MD; Guimarães TR; Fonseca LM; de Almeida Pordeus I; Mesquita RA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan; 103(1):64-71. PubMed ID: 17178496
[TBL] [Abstract][Full Text] [Related]
51. Oral Hairy Leukoplakia in Patients With No Evidence of Immunosuppression: A Case Series and Review of the Literature.
Darling MR; Alkhasawneh M; Mascarenhas W; Chirila A; Copete M
J Can Dent Assoc; 2018 May; 84():i4. PubMed ID: 31199724
[TBL] [Abstract][Full Text] [Related]
52. Oral lesions as an important marker for HIV progression.
Braz-Silva PH; Schussel JL; López Ortega K; Gallottini M
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469724
[TBL] [Abstract][Full Text] [Related]
53. Knowledge, attitudes and practices of oral health care workers in Lesotho regarding the management of patients with oral manifestations of HIV/AIDS.
Ramphoma KJ; Naidoo S
SADJ; 2014 Nov; 69(10):446, 448-53. PubMed ID: 26506796
[TBL] [Abstract][Full Text] [Related]
54. Oral manifestations in HIV/AIDS infected patients from India.
Sharma G; Pai KM; Suhas S; Ramapuram JT; Doshi D; Anup N
Oral Dis; 2006 Nov; 12(6):537-42. PubMed ID: 17054765
[TBL] [Abstract][Full Text] [Related]
55. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda.
Tirwomwe JF; Rwenyonyi CM; Muwazi LM; Besigye B; Mboli F
Clin Oral Investig; 2007 Sep; 11(3):289-92. PubMed ID: 17476537
[TBL] [Abstract][Full Text] [Related]
56. The association between cigarette smoking and selected HIV-related medical conditions.
Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia.
Guteta S; Feleke Y; Fekade D; Neway M; Diro E
Ethiop Med J; 2008 Oct; 46(4):349-57. PubMed ID: 19271399
[TBL] [Abstract][Full Text] [Related]
58. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
59. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.
Lifson AR; Hilton JF; Westenhouse JL; Canchola AJ; Samuel MC; Katz MH; Buchbinder SP; Hessol NA; Osmond DH; Shiboski S
AIDS; 1994 Jan; 8(1):73-9. PubMed ID: 8011239
[TBL] [Abstract][Full Text] [Related]
60. Clinical manifestations of infection with human immunodeficiency virus among adolescents in Louisiana.
Fuller C; Clark RA; Kissinger P; Abdalian SE
J Adolesc Health; 1996 Jun; 18(6):422-8. PubMed ID: 8803734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
